IntegenX integenx.com


Public list: Digital Health (5963) Genomics (546)

IntegenX, headquartered in Pleasanton, California, is the market leader of Rapid human DNA identification technology. IntegenX technology platforms integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer products for DNA-based human identity testing for forensics and law enforcement applications.

IntegenX, headquartered in Pleasanton, California, is the market leader of Rapid human DNA identification technology. IntegenX technology platforms integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer product...Show all

Company (Acquired)

Phone: 925-701-3400

Fax:

5720 Stoneridge Dr
Suite 300
Pleasanton, 94588
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
IntegenX $89.2M Mar 19, 2018
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related IntegenX Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 11 investors

Competitors

Company Status Description Investors

OPX Biotechnologies

Boulder, Colorado, United States
AcquiredThe OPX EDGE (Efficiency Directed Genome Engineering) technology platform enables rapid, rational, and robust optimization of microbes and bioprocesses to manufacture bioproducts with equivalent performance and improved sustainability at lower cost compared to petroleum-based alternatives. Using OPX EDGE, we identify the genes that control microbial metabolism and then implement a comprehensive, rational genetic change strategy to simultaneously optimize microbial production pathways and vitalit...Show allLogin to see details

TaiGen Biotechnology

Taipei, Taiwan
IPO / Went publicTaiGen Biotechnology is a research-based and product-driven pharmaceutical company engaging in the development of novel therapeutics for infectious diseases, cancer and diabetes-related complications. TaiGen has a wholly-owned Beijing subsidiary with a proven capacity to conduct clinical trials and related registrations.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Microfluidic devices Aug 12, 2015 Sep 05, 2017 Patent
Linear valve arrays Jul 21, 2015 Aug 15, 2017 Patent
Universal sample preparation system and use in an integrated analysis system Nov 24, 2014 May 30, 2017 Patent
Housing for biochemical analysis apparatus Apr 27, 2015 Nov 22, 2016 Patent
Microfluidic devices with mechanically-sealed diaphragm valves Jun 30, 2014 May 17, 2016 Patent
See all 34 patents